Abstract
Summary
Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic–clonic seizures are a type of generalized seizures, which affect the entire brain and are the most common type of epileptic seizures. Grand mal seizures are caused by neurotransmitter imbalances, which can also be influenced by fatigue, lack of sleep, hypertension, stress, intense lighting, rapid motion, blood sugar level, anxiety, etc. The grand mal seizures consist of two phases, the tonic phase and the clonic phase. The tonic phase involves loss of consciousness and muscle twitching and the phase usually last only for a few seconds. The clonic phase consists of rapid muscle contraction and relaxation resulting in convulsions.
The global Grand Mal Seizure market size is projected to grow from US$ 19360 million in 2023 to US$ 22990 million in 2030; it is expected to grow at a CAGR of 2.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Grand Mal Seizure Industry Forecast” looks at past sales and reviews total world Grand Mal Seizure sales in 2023, providing a comprehensive analysis by region and market sector of projected Grand Mal Seizure sales for 2024 through 2030. With Grand Mal Seizure sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Grand Mal Seizure industry.
This Insight Report provides a comprehensive analysis of the global Grand Mal Seizure landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Grand Mal Seizure portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Grand Mal Seizure market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Grand Mal Seizure and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Grand Mal Seizure.
The Americas accounts for the significant market share owing to extensive use of medications and greater expenditure on the health care. Additionally, the fastest uptake of new technology and drugs in the US drives the global grand mal seizures market. The concentration of the major medical diagnostic device manufacturers in the developed regions is also adding fuel to the market. Europe is the second largest market due to a high disposable income and rising awareness about the grand mal seizures.
This report presents a comprehensive overview, market shares, and growth opportunities of Grand Mal Seizure market by product type, application, key players and key regions and countries.
Segmentation by type
Barbiturates
Hydantoin
Phenyltriazine
Iminostilbenes
Benzodiazepines
Aliphatic Carboxylic Acid
Others
Segmentation by application
Hospitals
Clinics
Academic and Research Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Johnson & Johnson
UCB Celltech
Abbott Laboratories
GlaxoSmithKline
Novartis
Sanofi
Takeda
Teva Pharmaceutical
The global Grand Mal Seizure market size is projected to grow from US$ 19360 million in 2023 to US$ 22990 million in 2030; it is expected to grow at a CAGR of 2.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Grand Mal Seizure Industry Forecast” looks at past sales and reviews total world Grand Mal Seizure sales in 2023, providing a comprehensive analysis by region and market sector of projected Grand Mal Seizure sales for 2024 through 2030. With Grand Mal Seizure sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Grand Mal Seizure industry.
This Insight Report provides a comprehensive analysis of the global Grand Mal Seizure landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Grand Mal Seizure portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Grand Mal Seizure market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Grand Mal Seizure and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Grand Mal Seizure.
The Americas accounts for the significant market share owing to extensive use of medications and greater expenditure on the health care. Additionally, the fastest uptake of new technology and drugs in the US drives the global grand mal seizures market. The concentration of the major medical diagnostic device manufacturers in the developed regions is also adding fuel to the market. Europe is the second largest market due to a high disposable income and rising awareness about the grand mal seizures.
This report presents a comprehensive overview, market shares, and growth opportunities of Grand Mal Seizure market by product type, application, key players and key regions and countries.
Segmentation by type
Barbiturates
Hydantoin
Phenyltriazine
Iminostilbenes
Benzodiazepines
Aliphatic Carboxylic Acid
Others
Segmentation by application
Hospitals
Clinics
Academic and Research Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Johnson & Johnson
UCB Celltech
Abbott Laboratories
GlaxoSmithKline
Novartis
Sanofi
Takeda
Teva Pharmaceutical
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Grand Mal Seizure Market Size 2019-2030
2.1.2 Grand Mal Seizure Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Grand Mal Seizure Segment by Type
2.2.1 Barbiturates
2.2.2 Hydantoin
2.2.3 Phenyltriazine
2.2.4 Iminostilbenes
2.2.5 Benzodiazepines
2.2.6 Aliphatic Carboxylic Acid
2.2.7 Others
2.3 Grand Mal Seizure Market Size by Type
2.3.1 Grand Mal Seizure Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Grand Mal Seizure Market Size Market Share by Type (2019-2024)
2.4 Grand Mal Seizure Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Academic and Research Centers
2.4.4 Others
2.5 Grand Mal Seizure Market Size by Application
2.5.1 Grand Mal Seizure Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Grand Mal Seizure Market Size Market Share by Application (2019-2024)
3 Grand Mal Seizure Market Size by Player
3.1 Grand Mal Seizure Market Size Market Share by Players
3.1.1 Global Grand Mal Seizure Revenue by Players (2019-2024)
3.1.2 Global Grand Mal Seizure Revenue Market Share by Players (2019-2024)
3.2 Global Grand Mal Seizure Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Grand Mal Seizure by Regions
4.1 Grand Mal Seizure Market Size by Regions (2019-2024)
4.2 Americas Grand Mal Seizure Market Size Growth (2019-2024)
4.3 APAC Grand Mal Seizure Market Size Growth (2019-2024)
4.4 Europe Grand Mal Seizure Market Size Growth (2019-2024)
4.5 Middle East & Africa Grand Mal Seizure Market Size Growth (2019-2024)
5 Americas
5.1 Americas Grand Mal Seizure Market Size by Country (2019-2024)
5.2 Americas Grand Mal Seizure Market Size by Type (2019-2024)
5.3 Americas Grand Mal Seizure Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Grand Mal Seizure Market Size by Region (2019-2024)
6.2 APAC Grand Mal Seizure Market Size by Type (2019-2024)
6.3 APAC Grand Mal Seizure Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Grand Mal Seizure by Country (2019-2024)
7.2 Europe Grand Mal Seizure Market Size by Type (2019-2024)
7.3 Europe Grand Mal Seizure Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Grand Mal Seizure by Region (2019-2024)
8.2 Middle East & Africa Grand Mal Seizure Market Size by Type (2019-2024)
8.3 Middle East & Africa Grand Mal Seizure Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Grand Mal Seizure Market Forecast
10.1 Global Grand Mal Seizure Forecast by Regions (2025-2030)
10.1.1 Global Grand Mal Seizure Forecast by Regions (2025-2030)
10.1.2 Americas Grand Mal Seizure Forecast
10.1.3 APAC Grand Mal Seizure Forecast
10.1.4 Europe Grand Mal Seizure Forecast
10.1.5 Middle East & Africa Grand Mal Seizure Forecast
10.2 Americas Grand Mal Seizure Forecast by Country (2025-2030)
10.2.1 United States Grand Mal Seizure Market Forecast
10.2.2 Canada Grand Mal Seizure Market Forecast
10.2.3 Mexico Grand Mal Seizure Market Forecast
10.2.4 Brazil Grand Mal Seizure Market Forecast
10.3 APAC Grand Mal Seizure Forecast by Region (2025-2030)
10.3.1 China Grand Mal Seizure Market Forecast
10.3.2 Japan Grand Mal Seizure Market Forecast
10.3.3 Korea Grand Mal Seizure Market Forecast
10.3.4 Southeast Asia Grand Mal Seizure Market Forecast
10.3.5 India Grand Mal Seizure Market Forecast
10.3.6 Australia Grand Mal Seizure Market Forecast
10.4 Europe Grand Mal Seizure Forecast by Country (2025-2030)
10.4.1 Germany Grand Mal Seizure Market Forecast
10.4.2 France Grand Mal Seizure Market Forecast
10.4.3 UK Grand Mal Seizure Market Forecast
10.4.4 Italy Grand Mal Seizure Market Forecast
10.4.5 Russia Grand Mal Seizure Market Forecast
10.5 Middle East & Africa Grand Mal Seizure Forecast by Region (2025-2030)
10.5.1 Egypt Grand Mal Seizure Market Forecast
10.5.2 South Africa Grand Mal Seizure Market Forecast
10.5.3 Israel Grand Mal Seizure Market Forecast
10.5.4 Turkey Grand Mal Seizure Market Forecast
10.5.5 GCC Countries Grand Mal Seizure Market Forecast
10.6 Global Grand Mal Seizure Forecast by Type (2025-2030)
10.7 Global Grand Mal Seizure Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Grand Mal Seizure Product Offered
11.1.3 Pfizer Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Grand Mal Seizure Product Offered
11.2.3 Johnson & Johnson Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 UCB Celltech
11.3.1 UCB Celltech Company Information
11.3.2 UCB Celltech Grand Mal Seizure Product Offered
11.3.3 UCB Celltech Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 UCB Celltech Main Business Overview
11.3.5 UCB Celltech Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Grand Mal Seizure Product Offered
11.4.3 Abbott Laboratories Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Grand Mal Seizure Product Offered
11.5.3 GlaxoSmithKline Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Grand Mal Seizure Product Offered
11.6.3 Novartis Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Grand Mal Seizure Product Offered
11.7.3 Sanofi Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Takeda
11.8.1 Takeda Company Information
11.8.2 Takeda Grand Mal Seizure Product Offered
11.8.3 Takeda Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda Latest Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Information
11.9.2 Teva Pharmaceutical Grand Mal Seizure Product Offered
11.9.3 Teva Pharmaceutical Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Teva Pharmaceutical Main Business Overview
11.9.5 Teva Pharmaceutical Latest Developments
12 Research Findings and Conclusion